Insider Transactions in Q2 2022 at Invo Bioscience, Inc. (INVO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Kevin Doody Medical Director |
SELL
Open market or private purchase
|
Direct |
177,306
-100.0%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Rebecca Messina Director |
BUY
Open market or private purchase
|
Direct |
9,868
+29.98%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Andrea Goren Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
52,632
+28.97%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Michael Jos. Campbell Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,526
+12.2%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Jeffrey Segal Director |
BUY
Open market or private purchase
|
Direct |
9,211
+24.61%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Trent D Davis Director |
BUY
Open market or private purchase
|
Direct |
11,184
+24.96%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Barbara Ryan Director |
BUY
Open market or private purchase
|
Direct |
10,526
+31.41%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Matthew K Szot Director |
BUY
Open market or private purchase
|
Direct |
14,474
+26.98%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Steve Shum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
58,885
+31.44%
|
$0
$0.95 P/Share
|